These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Positron emission tomography radioligands for dopamine transporters and studies in human and nonhuman primates. Volkow ND; Fowler JS; Ding YS; Wang GJ; Gatley SJ Adv Pharmacol; 1998; 42():211-4. PubMed ID: 9327881 [No Abstract] [Full Text] [Related]
3. Imaging of serotonin and dopamine transporters in the living human brain. Kuikka JT; Tiihonen J; Bergström KA; Karhu J; Hartikainen P; Viinamäki H; Länsimies E; Lehtonen J; Hakola P Eur J Nucl Med; 1995 Apr; 22(4):346-50. PubMed ID: 7607266 [TBL] [Abstract][Full Text] [Related]
4. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT. Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949 [TBL] [Abstract][Full Text] [Related]
5. Nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET. Tissingh G; Bergmans P; Winogrodzka A; Stoof JC; Wolters EC; Booij J; Van Royen EA J Nucl Med; 1997 Aug; 38(8):1271-2. PubMed ID: 9255164 [No Abstract] [Full Text] [Related]
6. Single-photon emission computed tomography of the dopamine transporter in parkinsonism. Seibyl JP J Neuroimaging; 1999 Oct; 9(4):223-8. PubMed ID: 10540602 [TBL] [Abstract][Full Text] [Related]
7. Simultaneous SPECT studies of pre- and postsynaptic dopamine binding sites in baboons. Dresel SH; Kung MP; Huang XF; Plössl K; Hou C; Meegalla SK; Patselas G; Mu M; Saffer JR; Kung HF J Nucl Med; 1999 Apr; 40(4):660-6. PubMed ID: 10210226 [TBL] [Abstract][Full Text] [Related]
8. Imaging of dopamine transporters and D2 receptors in patients with Parkinson's disease and multiple system atrophy. Knudsen GM; Karlsborg M; Thomsen G; Krabbe K; Regeur L; Nygaard T; Videbaek C; Werdelin L Eur J Nucl Med Mol Imaging; 2004 Dec; 31(12):1631-8. PubMed ID: 15583914 [TBL] [Abstract][Full Text] [Related]
9. Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study. Ouchi Y; Kanno T; Okada H; Yoshikawa E; Futatsubashi M; Nobezawa S; Torizuka T; Sakamoto M Ann Neurol; 1999 Nov; 46(5):723-31. PubMed ID: 10553989 [TBL] [Abstract][Full Text] [Related]
10. Effect of the haloperidol tetrahydropyridine metabolite 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-1,2,3,6- tetrahydropyridine on dopamine receptor and transporter binding. A nonhuman primate 123I-iodobenzamide and 2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane single photon emission computed tomographic study. Oliver DW; Dormehl IC; Van der Schyf CJ; Neumeyer JL; Hugo N; Keeve R; Rossouw NT; Müller-Gärtner HW; Castagnoli N Arzneimittelforschung; 1997 Jun; 47(6):692-9. PubMed ID: 9239444 [TBL] [Abstract][Full Text] [Related]
11. Applications of SPECT imaging of dopaminergic neurotransmission in neuropsychiatric disorders. Kugaya A; Fujita M; Innis RB Ann Nucl Med; 2000 Feb; 14(1):1-9. PubMed ID: 10770574 [TBL] [Abstract][Full Text] [Related]